Poster presentation of Reboost Phase II study with Vacc-4x at GLOBVAC conference
Step towards long lasting HIV viral control with repeated Vacc-4x immunizations (Bergen, Norway, 16 October 2013) Bionor Pharma ASA (OSE: BIONOR) is today giving a poster presentation of the Reboost Phase II study with Vacc-4x, which received a grant from GLOBVAC in 2012, at the GLOBVAC conference in Bergen. The poster is entitled “Towards Eradication …